Symptoms of Low Rhodiola Rosea: Causes and Treatment
Deficiency
Symptoms & causes
Rhodiola rosea is an adaptogenic herb, not a nutrient — no deficiency syndrome exists, and rigorous evidence for its stress-fatigue and mood benefits is limited; the "low rhodiola" framing is supplement marketing, not clinical medicine.
Rhodiola rosea is a flowering plant used in traditional medicine for stress and fatigue, but it is not an essential nutrient. The human body has no physiological requirement for its active compounds, rosavins and salidroside, so there is no such thing as a "rhodiola deficiency." While some small trials suggest it may help with stress-related burnout, the overall evidence is limited, and persistent fatigue should always be evaluated by a clinician to rule out treatable medical causes.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Rhodiola rosea (roseroot, golden root, arctic root) — a flowering plant native to cold, mountainous regions of Europe and Asia. Bioactive compounds: rosavins (rosavin, rosin, rosarin — tricinnamyl glycosides) and salidroside (p-tyrosol glucoside); proposed to act as adaptogens by increasing the body's resistance to physical and psychological stress. Not a nutrient; no RDA, AI, or EAR established.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Not applicable — botanical; no deficiency phenotype exists.
Don't wait
See a doctor if
- Supplement side effects reported: dizziness and dry mouth (most common)
- Possible sleep disturbance if taken in the evening (mild stimulant properties)
- Discuss with a clinician before use if experiencing fatigue or mood symptoms — to rule out treatable medical causes (thyroid disease, anemia, depression) before attributing them to "low rhodiola."
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- No deficiency population. Rhodiola rosea is used as a supplement for stress, fatigue, and cognitive performance; the people most studied are those with stress-related fatigue and burnout syndrome.
What causes low Rhodiola rosea (roseroot, golden root, arctic root) — a flowering plant native to cold, mountainous regions of Europe and Asia. Bioactive compounds: rosavins (rosavin, rosin, rosarin — tricinnamyl glycosides) and salidroside (p-tyrosol glucoside); proposed to act as adaptogens by increasing the body's resistance to physical and psychological stress. Not a nutrient; no RDA, AI, or EAR established.
- Not applicable.
How low levels are diagnosed
No diagnostic test applicable — there is no "rhodiola level" to measure and no deficiency state to diagnose.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Not applicable for deficiency. Taken as a standardized root extract; most commercial preparations are standardized to 3% rosavins and 1% salidroside (the ratio found in the whole root). Doses in clinical trials range from 200–680 mg/day of standardized extract; typical supplement capsules are 200–500 mg/dose. Traditional use: as a tea, tincture, or whole root preparation.
How to keep levels up
Not applicable.
When to see a clinician
Discuss with a clinician before using rhodiola for fatigue or mood symptoms — persistent fatigue may reflect thyroid disorders, anemia, depression, sleep apnea, or other treatable conditions; rhodiola should not replace clinical evaluation. Also discuss before use in pregnancy (safety data limited) or if taking antidepressants, stimulants, or diabetes medications (possible interactions).
Rhodiola Rosea Is Not a Nutrient: What 'Adaptogen' Actually Means
Rhodiola rosea is a flowering plant, not a vitamin, mineral, or essential nutrient — and your body has no physiological requirement for it. The term "adaptogen" is a traditional-use classification, not a rigorous pharmacological category recognized by the FDA, NIH, or EFSA.
The concept of adaptogens originated in Soviet-era research, where scientists sought substances that could nonspecifically increase the body's resistance to physical and psychological stress. Rhodiola was studied extensively in this context, particularly for enhancing athletic and military performance. Much of that early research, however, was published in Russian-language journals with methodological standards that do not meet modern clinical trial benchmarks.
When you see "low rhodiola" or "rhodiola deficiency" in supplement marketing, it is a commercial framing with no clinical meaning. The Institute of Medicine has never established a Recommended Dietary Allowance (RDA) or Adequate Intake (AI) for rosavins or salidroside. You cannot be deficient in something your body never evolved to require. This distinction matters because it reframes the conversation: rhodiola is not a missing piece of your biology — it is a botanical supplement with limited evidence for specific uses.
Bottom line
"Adaptogen" is a traditional-use term, not a FDA-regulated claim or a pharmacological category recognized by NIH; your body has no rhodiola requirement, making the "deficiency" framing pure supplement marketing.
Rosavins and Salidroside: The Bioactive Compounds and How They May Work
Rhodiola's proposed effects are attributed to two main classes of bioactive compounds: rosavins (rosavin, rosin, rosarin) and salidroside. Quality supplements are standardized to 3% rosavins and 1% salidroside, the ratio found in the whole root — and this standardization is important because different extracts can have markedly different compound profiles.
The mechanistic research, largely from preclinical studies, suggests several pathways. Rosavins and salidroside may inhibit monoamine oxidase (MAO-A and MAO-B), enzymes that break down serotonin, dopamine, and norepinephrine — which could theoretically elevate mood and reduce stress perception. Animal studies also point to activation of AMPK and DAF-16/FOXO pathways, which are involved in cellular stress resistance and longevity. Additionally, some research suggests rhodiola may modulate cortisol, the body's primary stress hormone.
These mechanisms are biologically plausible, but the leap from a rat study or a cell culture to a human taking a capsule is substantial. The key question is not whether rhodiola does something in a petri dish — it is whether those effects translate to meaningful, reproducible clinical outcomes in humans. On that front, the evidence is considerably thinner than most supplement marketing suggests.
Bottom line
The proposed mechanisms are biologically plausible but most are from in vitro or animal studies; the key question is whether these pathways translate to meaningful human clinical outcomes — and the evidence is limited.
What the Clinical Trials Actually Show: Stress, Fatigue, and Cognitive Performance
The National Center for Complementary and Integrative Health (NCCIH) states plainly that "rigorous evidence for benefits from rhodiola is limited." That is the honest starting point — and it is a more cautious position than what you will find on most supplement review sites.
The most frequently cited human trial is a 2009 study by Olsson et al., which examined rhodiola in patients with stress-related burnout. Participants taking 576 mg of standardized extract daily showed improvements in fatigue and attention compared to placebo. A 2012 trial in students during exam stress also reported reduced mental fatigue and improved well-being. These are real signals, but the trials were small — typically 60 to 120 participants — and short in duration, often 4 to 12 weeks.
The cognitive performance evidence is similarly mixed. Some studies suggest modest improvements in working memory and mental processing speed under stress, but these findings have not been consistently replicated in larger, well-controlled trials. The Soviet-era research base, while extensive, carries inherent bias concerns given its origins in state-sponsored sports and military programs. Publication bias — where positive results are more likely to be published than null findings — is a known problem in the supplement literature.
What is missing is the kind of large, multi-center, independently funded RCT that would move rhodiola from "interesting preliminary signal" to "evidence-based recommendation." Until that exists, the honest clinical position is that rhodiola may help some people with stress-related fatigue, but the evidence is not strong enough to recommend it over interventions with more robust support.
Bottom line
The honest verdict per NCCIH: some signal for stress-fatigue and burnout, but trials are small, short, and methodologically heterogeneous; Healthline-level content presents this evidence far more confidently than the primary literature warrants.
When Fatigue Is Not a Rhodiola Deficiency: Medical Causes to Rule Out First
Persistent fatigue is a real and debilitating symptom — but it is not caused by a lack of rhodiola. Before reaching for an adaptogen, several treatable medical conditions should be ruled out with a clinician. This is the step that supplement marketing conveniently skips.
Hypothyroidism is a leading cause of unexplained fatigue, particularly in women, and is diagnosed with a simple TSH blood test. Iron-deficiency anemia, which can cause profound tiredness, weakness, and brain fog, is identified through a complete blood count (CBC) and ferritin level. Vitamin B12 deficiency — which can mimic the mental fatigue and cognitive sluggishness that rhodiola is marketed to address — is common in vegetarians, older adults, and people taking metformin or long-term acid-suppressing medications.
Vitamin D insufficiency is another fatigue contributor that is widespread and easily corrected. Sleep apnea, often undiagnosed, causes daytime sleepiness that no supplement will fix. Depression and anxiety disorders frequently present with fatigue as a primary symptom and require proper mental health evaluation, not self-treatment with botanicals. For GLP-1 users specifically, reduced food intake can lower dietary intake of iron, B12, and vitamin D — making these deficiencies more relevant, not less.
A thyroid panel, CBC, ferritin, B12, and vitamin D test costs far less than months of rhodiola supplementation and addresses the actual problem if one exists. If those tests are normal and fatigue persists, the conversation with your clinician can then include whether an adaptogen like rhodiola is worth trying — but it should not be the first move.
Bottom line
Before reaching for an adaptogen for fatigue, rule out the treatable medical causes — a thyroid panel, CBC, ferritin, B12, and vitamin D test costs far less than months of rhodiola supplements and addresses the actual problem if one exists.
Rhodiola Rosea and GLP-1 Therapy: Stress Eating, Cortisol, and Realistic Expectations
GLP-1 users managing weight with semaglutide or tirzepatide often also navigate chronic stress — and the overlap between stress-driven eating and rhodiola's proposed cortisol-modulating effects creates a plausible narrative. Chronic stress elevates cortisol, which can increase appetite and drive cravings for calorie-dense foods. If rhodiola blunts that cortisol response, the logic goes, it might help GLP-1 users manage stress eating.
This is a mechanistically interesting hypothesis, but it is not supported by clinical trial evidence. No RCT has tested whether rhodiola enhances weight loss or complements GLP-1 therapy. The cortisol-modulating data in humans is inconsistent, and the studies that do exist were not conducted in populations taking GLP-1 receptor agonists. The gap between an appealing mechanism and demonstrated clinical benefit is wide.
There is also a safety consideration. Rhodiola's mild MAO-inhibitory activity means it could theoretically interact with antidepressants — particularly SSRIs, SNRIs, and MAOIs — which are prescribed at higher rates in populations seeking weight management. The combination could increase serotonin levels and, in rare cases, contribute to serotonin syndrome. This is not a high-probability risk at typical rhodiola doses, but it is a conversation worth having with a pharmacist or prescribing clinician before adding the supplement.
Rhodiola also has mild stimulant properties, so evening dosing can disrupt sleep — and poor sleep is itself a driver of weight gain and metabolic dysfunction. If you are considering rhodiola while on a GLP-1 medication, the practical steps are: take it in the morning, start with a low dose, and discuss it with the clinician managing your GLP-1 prescription, especially if you take any psychiatric medications.
Bottom line
The stress-eating narrative makes rhodiola seem relevant to GLP-1 users, but there is no trial evidence it enhances weight loss or complements GLP-1 therapy; the potential MAO interaction with antidepressants warrants a pharmacist conversation.
What most pages leave out
The key gap in competitor content is the confidence level placed on the adaptogen evidence. NCCIH explicitly states rigorous evidence is limited; Healthline and most supplement review sites present rhodiola as having "proven" stress and fatigue benefits. The other honest note: many of the foundational trials come from Soviet-era research with methodological concerns, and the handful of modern Western RCTs are small and short. Persistent fatigue — the primary symptom driving rhodiola searches — has real medical causes that should be investigated clinically, not supplemented around.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
There are none; rhodiola is not a nutrient and no deficiency syndrome exists. Persistent fatigue and low stress resilience are real symptoms — but they reflect medical or lifestyle factors, not a "rhodiola deficiency."
Some small trials show benefit for stress-related fatigue and burnout; NCCIH's position is that rigorous evidence is limited. It is not a substitute for investigating treatable medical causes of fatigue like thyroid disorders or anemia.
Rosavins (rosavin, rosin, rosarin) and salidroside; quality supplements are standardized to 3% rosavins and 1% salidroside to match the ratio found in the whole root.
Clinical trials have used doses ranging from 200 to 680 mg per day of a standardized extract. Because rhodiola has mild stimulant properties, it is best taken earlier in the day to avoid sleep disruption.
Rhodiola may have mild MAO-inhibitory activity, which could theoretically interact with antidepressants and other serotonergic drugs. Discuss with a pharmacist or clinician before use if you take any psychiatric medication, stimulants, or diabetes drugs.
It is generally well-tolerated in clinical trials at recommended doses; the most common side effects are dizziness and dry mouth. Safety in pregnancy is not established, so discuss with a clinician before use.
No clinical trial evidence supports rhodiola for weight loss. The stress-cortisol-appetite connection is mechanistically plausible but has not been validated in human RCTs.
There is no established synergy and a potential drug interaction via MAO inhibition. Discuss with your prescribing clinician before adding rhodiola, especially if you are also taking antidepressants.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
What Are the Symptoms of Low Aloe Vera? Causes and Treatment
Aloe vera is a plant, not a nutrient—no deficiency exists. Learn the critical gel vs. latex safety distinction, FDA actions, and oral use risks for GLP-1 users.
Read moreSymptoms of Low Barley Grass: Why This Isn’t a Real Deficiency
Barley grass is a plant food, not an essential nutrient. There is no barley grass deficiency. Learn what it actually contains, what the weak evidence shows, and the real safety risks.
Read moreSymptoms of Low 5-HTP (5-Hydroxytryptophan): Causes & Treatment
5-HTP is a serotonin precursor, not a nutrient you can be deficient in. Learn what low serotonin activity means, the real risks of 5-HTP supplements, and safer alternatives.
Read moreSymptoms of Low Astaxanthin: Causes and Treatment
Astaxanthin is a powerful antioxidant found in salmon and shrimp, but there's no such thing as a deficiency. Learn what low intake actually means and what the science says.
Read moreSymptoms of Low Apple Cider Vinegar: Causes and Treatment
Apple cider vinegar is a condiment, not a nutrient — no deficiency syndrome exists. Learn what the research actually shows about ACV, blood sugar, and safety risks.
Read moreSymptoms of Low Ashwagandha: Causes and Treatment
Ashwagandha is an adaptogenic herb, not a nutrient. No deficiency syndrome exists. Learn what the evidence shows for stress, thyroid, and safety risks like thyrotoxicosis.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.